SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
18-Apr-24 8:20 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Apr-24 | Grant | 179,850 | -- | -- | 6% 2.96M to 3.14M | |
07-Mar-24 4:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 05-Mar-24 | Market Sale | 4,135 | $18.73 | $77,439.90 | (< 1%) 2.96M to 2.96M | 11% |
28-Feb-24 6:20 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 26-Feb-24 | Grant | 126,667 | -- | -- | 4% 2.84M to 2.96M | |
11-Jan-24 5:11 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 09-Jan-24 | Market Sale | 5,841 | $16.33 | $95,372.40 | (< 1%) 2.84M to 2.84M | (2%) |
20-Mar-23 8:31 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Mar-23 | Grant | 50,000 | -- | -- | 2% 2.89M to 2.94M | |
20-Mar-23 8:31 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Mar-23 | Sale (Planned) | 100,000 | $31.86 | $3,186,240.00 | (3%) 2.94M to 2.84M | |
10-Jan-23 7:12 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 06-Jan-23 | Sale (Planned) | 5,968 | $36.30 | $216,629.00 | < 1% 2.89M to 2.89M | |
06-May-22 4:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 05-May-22 | Option Exercise | 334,520 | $0.37 | $123,772.00 | 13% 2.56M to 2.9M | |
10-Jan-22 8:28 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 06-Jan-22 | Grant | 75,000 | -- | -- | 3% 2.48M to 2.56M | |
10-Jan-22 8:28 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 06-Jan-22 | Conversion | 4,870 | -- | -- | < 1% 2.56M to 2.56M |